These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1082 related articles for article (PubMed ID: 11560041)

  • 1. [Systemic sclerosis (scleroderma) without scleroderma].
    Nadashkevych ON
    Lik Sprava; 2001; (3):93-4. PubMed ID: 11560041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Morphological changes in the skin in scleroderma in the process of treatment with unithiol].
    Dubinskiĭ AA; Tseraidis GS; Guĭda PP; Petrusenko EA; Babykina EA
    Vrach Delo; 1978 Oct; (10):112-4. PubMed ID: 716343
    [No Abstract]   [Full Text] [Related]  

  • 3. [How I explore ... the skin functional involvement in scleroderma].
    Hermanns-Lê T; Piérard-Franchimont C; Piérard GE; André B; De Roover C; Renwart L; Delvenne P
    Rev Med Liege; 2013 Mar; 68(3):141-7. PubMed ID: 23614323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ichthyotic-appearing skin changes associated with childhood morphea, systemic sclerosis, and systemic lupus erythematosus/scleroderma overlap.
    Williams CM; Storm CA; Burns C; Rigby W; Dinulos JG
    Pediatr Dermatol; 2010; 27(2):170-3. PubMed ID: 20537069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous and subcutaneous inflammatory sclerosis syndromes.
    Doyle JA; Connolly SM; Winkelmann RK
    Arch Dermatol; 1982 Nov; 118(11):886-90. PubMed ID: 7138043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic and localized scleroderma in children: current and future treatment options.
    Rosenkranz ME; Agle LM; Efthimiou P; Lehman TJ
    Paediatr Drugs; 2006; 8(2):85-97. PubMed ID: 16608370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peristomal morphoea in a patient with systemic sclerosis.
    Jiang KW; Zagarella SS; Chan L; Harris A
    Australas J Dermatol; 2020 Nov; 61(4):e451-e452. PubMed ID: 32567671
    [No Abstract]   [Full Text] [Related]  

  • 8. [Scleroatrophic lichen and its relation to scleroderma].
    Kalamkarian AA; Fedorova EG
    Vestn Dermatol Venerol; 1982; (12):4-7. PubMed ID: 7158014
    [No Abstract]   [Full Text] [Related]  

  • 9. Capillary abnormalities, Raynaud's phenomenon, and systemic sclerosis in patients with localized scleroderma.
    Maricq HR
    Arch Dermatol; 1992 May; 128(5):630-2. PubMed ID: 1575525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Scleroderma in children].
    Frati Munari AC; Culebro Nieves G; Velázquez E; Podoswa G
    Bol Med Hosp Infant Mex; 1979; 36(2):201-14. PubMed ID: 758191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin sclerosis as a manifestation of POEMS syndrome.
    Hasegawa M; Orito H; Yamamoto K; Matsushita T; Hamaguchi Y; Fujimoto M; Takehara K
    J Dermatol; 2012 Nov; 39(11):922-6. PubMed ID: 22724593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presentations and treatment of childhood scleroderma: localized scleroderma, eosinophilic fasciitis, systemic sclerosis, and graft-versus-host disease.
    Hedrich CM; Fiebig B; Hahn G; Suttorp M; Gahr M
    Clin Pediatr (Phila); 2011 Jul; 50(7):604-14. PubMed ID: 21525084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Madecassol treatment of systemic and localized scleroderma].
    Guseva NG; Starovoĭtova MN; Mach ES
    Ter Arkh; 1998; 70(5):58-61. PubMed ID: 9644746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Systemic sclerosis--clinical course and treatment possibilities].
    Szymańska E; Maj M; Rudnicka L
    Przegl Lek; 2005; 62(12):1538-41. PubMed ID: 16786791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of scleroderma with PUVA therapy.
    Kanekura T; Fukumaru S; Matsushita S; Terasaki K; Mizoguchi S; Kanzaki T
    J Dermatol; 1996 Jul; 23(7):455-9. PubMed ID: 8772023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Classification of circumscribed scleroderma. A multicenter study of 286 patients. The Scleroderma Study Group of the Society of Dermatologic Research].
    Hautarzt; 1990 Jan; 41(1):16-21. PubMed ID: 2179167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localized and systemic scleroderma show different histological responses to methotrexate therapy.
    Seyger MM; van den Hoogen FH; van Vlijmen-Willems IM; van de Kerkhof PC; de Jong EM
    J Pathol; 2001 Apr; 193(4):511-6. PubMed ID: 11276011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulating circulation to end stasis in scleroderma.
    Yuan X; Li JD; Chen WJ; Li ZS; Zhu HT; Liu JW; Zhu MJ
    Chin Med J (Engl); 1981 Feb; 94(2):85-93. PubMed ID: 6786844
    [No Abstract]   [Full Text] [Related]  

  • 19. Topical tocoretinate improved hypertrophic scar, skin sclerosis in systemic sclerosis and morphea.
    Mizutani H; Yoshida T; Nouchi N; Hamanaka H; Shimizu M
    J Dermatol; 1999 Jan; 26(1):11-7. PubMed ID: 10063206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic and localized scleroderma.
    Chung L; Lin J; Furst DE; Fiorentino D
    Clin Dermatol; 2006; 24(5):374-92. PubMed ID: 16966019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.